Intrust Bank NA Cuts Stake in HCA Healthcare, Inc. $HCA

Intrust Bank NA lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 69,298 shares of the company’s stock after selling 2,665 shares during the quarter. HCA Healthcare comprises approximately 2.7% of Intrust Bank NA’s investment portfolio, making the stock its 9th biggest holding. Intrust Bank NA’s holdings in HCA Healthcare were worth $32,352,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of HCA. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. NewEdge Advisors LLC raised its holdings in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $2,073,000. Finally, Sei Investments Co. raised its holdings in shares of HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on HCA shares. Jefferies Financial Group restated a “buy” rating and set a $525.00 target price on shares of HCA Healthcare in a report on Friday, April 24th. Wells Fargo & Company lowered their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Sanford C. Bernstein lowered their target price on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a report on Tuesday, April 28th. Royal Bank Of Canada lowered their target price on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, The Goldman Sachs Group upped their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Price Performance

NYSE:HCA opened at $403.98 on Wednesday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a market cap of $89.62 billion, a P/E ratio of 13.89, a P/E/G ratio of 1.34 and a beta of 1.18. The firm’s fifty day moving average price is $473.90 and its two-hundred day moving average price is $485.20.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.